Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Company profile
Ticker
BDX, BOX-GM, BDX
Exchange
Website
CEO
Thomas Polen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Accuri Cytometers, Inc. • Adaptec Medical Devices LLC • Alverix, Inc. • Bard Access Systems, Inc. • Bard Acquisition Sub, Inc. • Bard ASDI, Inc. • Bard Brachytherapy, Inc. • Bard Devices, Inc. • Bard Global Holdings I LLC • Bard Global Holdings II LLC ...
IRS number
220760120
BDX stock data
Latest filings (excl ownership)
8-K
Dave Hickey Announces Intent to Retire from BD
27 Feb 24
CERT
Certification of approval for exchange listing
9 Feb 24
8-A12B
Registration of securities on exchange
9 Feb 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8 Feb 24
424B2
Prospectus for primary offering
7 Feb 24
424B2
Prospectus for primary offering
7 Feb 24
8-K
Other Events
6 Feb 24
FWP
Free writing prospectus
5 Feb 24
FWP
Free writing prospectus
5 Feb 24
424B2
Prospectus for primary offering
5 Feb 24
Transcripts
BDX
Earnings call transcript
2024 Q1
1 Feb 24
BDX
Earnings call transcript
2023 Q4
9 Nov 23
BDX
Earnings call transcript
2023 Q3
3 Aug 23
BDX
Earnings call transcript
2023 Q2
4 May 23
BDX
Earnings call transcript
2023 Q1
2 Feb 23
BDX
Earnings call transcript
2022 Q4
10 Nov 22
BDX
Earnings call transcript
2022 Q3
4 Aug 22
BDX
Earnings call transcript
2022 Q2
5 May 22
BDX
Earnings call transcript
2022 Q1
3 Feb 22
BDX
Earnings call transcript
2021 Q4
4 Nov 21
Latest ownership filings
4
Shana Carol Neal
5 Apr 24
4
Thomas J Spoerel
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Michael David Garrison
5 Mar 24
4
Thomas J Spoerel
5 Mar 24
4
Antoine C Ezell
5 Mar 24
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
16 Feb 24
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Christopher Ian Montague Jones
7 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
60.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1280 |
Opened positions | 136 |
Closed positions | 366 |
Increased positions | 390 |
Reduced positions | 541 |
13F shares | Current |
---|---|
Total value | 37.87 tn |
Total shares | 175.59 mm |
Total puts | 229.48 k |
Total calls | 177.56 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 26.12 mm | $6.37 tn |
STT State Street | 12.92 mm | $3.15 tn |
MS Morgan Stanley | 10.71 mm | $2.61 tn |
T. Rowe Price | 10.39 mm | $2.53 bn |
Wellington Management | 6.67 mm | $1.63 tn |
JPM JPMorgan Chase & Co. | 4.69 mm | $1.14 tn |
Massachusetts Financial Services | 4.03 mm | $983.30 bn |
BK Bank Of New York Mellon | 3.89 mm | $949.34 bn |
IVZ Invesco | 3.76 mm | $916.22 bn |
WFC Wells Fargo & Co. | 3.73 mm | $910.44 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Apr 24 | Shana Carol Neal | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 1,921 | 0.00 | 16,389 |
14 Mar 24 | Thomas J Spoerel | Common Stock | Sell | Dispose S | No | No | 238.29 | 282 | 67.20 k | 2,276 |
1 Mar 24 | Michael David Garrison | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 178 | 0.00 | 7,096 |
1 Mar 24 | Thomas J Spoerel | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 36 | 0.00 | 2,558 |
1 Mar 24 | Antoine C Ezell | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 282 | 0.00 | 9,320 |
News
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak
25 Apr 24
Becton, Dickinson Announced Global Commercial Release Of New Cell Sorters To Enable More Researchers In Broader Range Of Fields, Including Cell Biology, Cancer Research And Immunology In Traditional Flow Cytometry Experiments
5 Apr 24
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
2 Apr 24
AngioDynamics Reports Settlement Of All Patent Litigation With C.R. Bard
1 Apr 24
Peering Into Becton Dickinson's Recent Short Interest
29 Mar 24
Press releases
BD Named a Best Employer for Excellence in Employee Well-Being
9 Apr 24
BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
5 Apr 24
BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
5 Apr 24
BD to Announce Financial Results for its Second Quarter of Fiscal 2024
4 Apr 24
BD to Announce Financial Results for its Second Quarter of Fiscal 2024
4 Apr 24